NCT02992756View on ClinicalTrials.gov

Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques

PHASE3TerminatedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Low Ovarian Reserve
Interventions
DRUG

Growth Factors

one dose 3-6 mL of PRP obtained by PRGF Endoret

Trial Locations (1)

48940

IVI Bilbao, Leioa

Sponsors

Lead Sponsor

IVI Bilbao
All Listed Sponsors
lead

IVI Bilbao

OTHER

NCT02992756 - Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques | Biotech Hunter | Biotech Hunter